Utah Medical Products UTMD Deferred Foreign Income Tax Expense Benefit
Deferred Foreign Income Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's deferred foreign income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's deferred foreign income tax expense benefit?
- Utah Medical Products (UTMD) reported deferred foreign income tax expense benefit of -$139.75K in Q4 2025.
- How has Utah Medical Products's deferred foreign income tax expense benefit changed year-over-year?
- Utah Medical Products's deferred foreign income tax expense benefit decreased by 8.3% year-over-year, from -$129K to -$139.75K.
- What is the long-term trend for Utah Medical Products's deferred foreign income tax expense benefit?
- Over 2 years (2023 to 2025), Utah Medical Products's deferred foreign income tax expense benefit has grown at a 20.2% compound annual growth rate (CAGR), from -$387K to -$559K.
- What does deferred foreign income tax expense benefit mean?
- This metric represents the change in deferred tax assets or liabilities resulting from temporary differences in foreign jurisdictions. It reflects the future tax consequences of current financial transactions that will be recognized for tax purposes in later periods. It is a critical indicator of the long-term tax implications of the company's international operations.